Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review (Q34788267)
scientific article
Language:
Current Data About Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review
(P31) (Q13442814)
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P304) 288-323
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P478) 7
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P577) Tuesday, January 1, 2002
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P921) (Q420207)
(P887)

(Q238512)
(P887)

(P1433) (Q2122327)
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P1476) "Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review" (language: en)
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P2093) M Malet-Martino
(P1545) 1
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

R Martino
(P1545) 2
(P248)
(P698) 12185293
(P813) Friday, August 4, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1634/THEONCOLOGIST.7-4-288
(P698) 12185293
(P5875) 11202763